본문 바로가기
KERD
논문KCI 등재

Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: a 20-year systematic review

Okoye Jude Ogechukwu|Ofodile Chukwudi Amaechi|Adeleke Oluwaseun Kelechi|Obioma Okechi
한국역학회 (Korean Society of Epidemiology)|2021.01|Epidemiology and Health|제43권 |pp. 1-11|DOI 10.4178/epih.e2021039

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

IncidenceAfricaVaccinesVirusesCervix Uteri

초록

OBJECTIVES: This review assessed the rate of high-risk human papillomavirus (HPV) infection among women living in sub-Saharan Africa. It also determined the prevalence of high-risk HPV (hrHPV) among human immunodeficiency virus (HIV) seropositive (HIV+) and seronegative (HIV-) women in sub-Saharan Africa, pre-2010 and post-2010.METHODS: In this systematic review, Google Scholar, PubMed Central, and Embase were searched to identify cohort and case-control studies that investigated the relationship between HIV and HPV infection. The database searches yielded 17 studies published between 1999 and 2018.RESULTS: In the general population, the prevalence of any HPV/multiple HPV infections was higher among HIV+ (53.6/22.6%) than among HIV- women (26.5/7.3%) with odds ratios of 3.22 and 3.71, respectively (95% confidence interval, 3.00 to 3.42 and 2.39 to 5.75, p< 0.001). The prevalent HPV genotypes among HIV+ and HIV- women diagnosed with invasive cervical cancer (ICC) were HPV-16/18 and HPV-45. The prevalence of HPV-16, HPV-18, and HPV-45 was lower in 1999-2010 (3.8, 1.7, and 0.8%, respectively) than in 2011-2018 (19.1, 6.0, and 3.6%, respectively). Among women diagnosed with ICC, HIV+ women had a higher prevalence of HPV-56, HPV-31, and HPV-51 (7.3, 5.3, and 3.3%, respectively) than HIV- women (1.3, 2.2, and 0.4%, p< 0.001, p= 0.050, and p= 0.013, respectively).CONCLUSIONS: The prevalence of HPV infection, multiple HPV infections, and non-vaccine HPV types were higher among HIV+ women than among HIV- women in sub-Saharan Africa. Although HIV infection influences the distribution of HPV types, this study suggests that cervical cancer incidence in sub-Saharan Africa is primarily driven by the prevalence of vaccine hrHPVs, especially HPV-16 and HPV-18.

Abstract

OBJECTIVES: This review assessed the rate of high-risk human papillomavirus (HPV) infection among women living in sub-Saharan Africa. It also determined the prevalence of high-risk HPV (hrHPV) among human immunodeficiency virus (HIV) seropositive (HIV+) and seronegative (HIV-) women in sub-Saharan Africa, pre-2010 and post-2010.METHODS: In this systematic review, Google Scholar, PubMed Central, and Embase were searched to identify cohort and case-control studies that investigated the relationship between HIV and HPV infection. The database searches yielded 17 studies published between 1999 and 2018.RESULTS: In the general population, the prevalence of any HPV/multiple HPV infections was higher among HIV+ (53.6/22.6%) than among HIV- women (26.5/7.3%) with odds ratios of 3.22 and 3.71, respectively (95% confidence interval, 3.00 to 3.42 and 2.39 to 5.75, p< 0.001). The prevalent HPV genotypes among HIV+ and HIV- women diagnosed with invasive cervical cancer (ICC) were HPV-16/18 and HPV-45. The prevalence of HPV-16, HPV-18, and HPV-45 was lower in 1999-2010 (3.8, 1.7, and 0.8%, respectively) than in 2011-2018 (19.1, 6.0, and 3.6%, respectively). Among women diagnosed with ICC, HIV+ women had a higher prevalence of HPV-56, HPV-31, and HPV-51 (7.3, 5.3, and 3.3%, respectively) than HIV- women (1.3, 2.2, and 0.4%, p< 0.001, p= 0.050, and p= 0.013, respectively).CONCLUSIONS: The prevalence of HPV infection, multiple HPV infections, and non-vaccine HPV types were higher among HIV+ women than among HIV- women in sub-Saharan Africa. Although HIV infection influences the distribution of HPV types, this study suggests that cervical cancer incidence in sub-Saharan Africa is primarily driven by the prevalence of vaccine hrHPVs, especially HPV-16 and HPV-18.

참고문헌 (47)

  1. Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
  2. Black E, "Prevention of cervical cancer in sub-Saharan Africa: the advantages and challenges of HPV vaccination", Vaccines(Basel), 6, pp.61~ (2018)
  3. Jedy-Agba E, "Trends in cervical cancer incidence in sub-Saharan Africa", Br J Cancer, 123, pp.148~154 (2020)
  4. "Fact sheet 2021: preliminary UNAIDS 2021 epidemiological estimates"[URL]
  5. Dwyer-Lindgren L, "Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017", Nature, 570, pp.189~193 (2019)
  6. Massad LS, "Long-term cumulative detection of human papillomavirus among HIV seropositive women", AIDS, 28, pp.2601~2608 (2014)
  7. Rowhani-Rahbar A, "The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women", J Infect Dis, 196, pp.887~894 (2007)
  8. Clifford GM, "Carcinogenicity of human papillomavirus(HPV)types in HIV-positive women : a meta-analysis from HPV infection to cervical cancer", Clin Infect Dis, 64, pp.1228~1235 (2017)
  9. Abraham AG, "Invasive cervical cancer risk among HIV-infected women is a function of CD4 count and screening", J Acquir Immune Defic Syndr, 63, pp.e163~ (2013)
  10. Belglaiaa E, "Human papillomavirus genotypes among women with or without HIV infection : an epidemiological study of Moroccan women from the Souss area", Infect Agent Cancer, 10, pp.44~ (2015)
  11. Hanisch RA, "Influence of HIV-1 and", or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa, 2013, pp.58, 696~702
  12. Dames DN, "High-risk cervical human papillomavirus infections among human immunodeficiency virus-positive women in the Bahamas", PLoS One, 9, pp.e85429~ (2014)
  13. Ouladlahsen A, "The human papillomavirus among women living with human immunodeficiency virus in Morocco : a prospective crosssectional study", J Infect Dev Ctries, 12, pp.477~484 (2018)
  14. Keller MJ, "Racial differences in HPV types amongst US women with HIV and cervical precancer", AIDS, 32, pp.2821~2826 (2018)
  15. Amponsah-Dacosta E, "Health systems constraints and facilitators of human papillomavirus immunization programmes in sub-Saharan Africa : a systematic review", Health Policy Plan, 35, pp.701~717 (2020)
  16. Klein C, "How the cervical microbiota contributes to cervical cancer risk in sub-Saharan Africa", Front Cell Infect Microbiol, 10, pp.23~ (2020)
  17. Meites E, "Human papillomavirus vaccination for adults : updated recommendations of the Advisory Committee on Immunization Practices", MMWR Morb Mortal Wkly Rep, 68, pp.698~702 (2019)
  18. Yakub MM, "Human papillomavirus correlates of high grade cervical dysplasia among HIV-Infected women at a major treatment centre in Nigeria : a cross-sectional study", Pan Afr Med J, 33, pp.125~ (2019)
  19. Menon SS, "Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya", Infect Agent Cancer, 11, pp.17~ (2016)
  20. Mudini W, "Human papillomavirus genotypes in invasive cervical carcinoma in HIV-seropositive and HIV-seronegative women in Zimbabwe", J Acquir Immune Defic Syndr, 79, pp.e1~e6 (2018)
  21. Akarolo-Anthony SN, "Age-specific prevalence of human papilloma virus infection among Nigerian women", BMC Public Health, 14, pp.656~ (2014)
  22. Bello BD, "Cervical infections by multiple human papillomavirus(HPV)genotypes : prevalence and impact on the risk of precancerous epithelial lesions", J Med Virol, 81, pp.703~712 (2009)
  23. Yar DD, "Genotypic characterisation of human papillomavirus infections among persons living with HIV infection; a case-control study in Kumasi, Ghana", Trop Med Int Health, 21, pp.275~282 (2016)
  24. Liberati A, "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions : explanation and elaboration", PLoS Med, 6, pp.e1000100~ (2009)
  25. Moher D, "Preferred reporting items for systematic reviews and meta-analyses : the PRISMA statement", PLoS Med, 6, pp.e1000097~ (2009)
  26. "Assessing cardiovascular risk: systematic evidence review from the Risk Assessment Work Group, 2013"[URL]
  27. Sanderson S, "Tools for assessing quality and susceptibility to bias in observational studies in epidemiology : a systematic review and annotated bibliography", Int J Epidemiol, 36, pp.666~676 (2007)
  28. Sterne JA, "ROBINS-I: a tool for assessing risk of bias in nonrandomised studies of interventions", BMJ, 355, pp.i4919~ (2016)
  29. Diop-Ndiaye H, "Human papillomavirus infection in Senegalese female sex workers", Papillomavirus Res, 7, pp.97~101 (2019)
  30. Dols JA, "HPV type distribution and cervical cytology among HIV-positive Tanzanian and South African women", ISRN Obstet Gynecol, 2012, pp.514146~ (2012)
  31. Denny L, "Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women", Obstet Gynecol, 111, pp.1380~1387 (2008)
  32. Mpunga T, "Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status", Int J Cancer, 146, pp.1514~1522 (2020)
  33. Marembo T, "Use of multiplex polymerase chain reaction for detection of high-risk human papillomavirus genotypes in women attending routine cervical cancer screening in Harare", Intervirology, 62, pp.90~95 (2019)
  34. Maranga IO, "HIV Infection alters the spectrum of HPV subtypes found in cervical smears and carcinomas from Kenyan women", Open Virol J, 7, pp.19~27 (2013)
  35. Banura C, "Infection with human papillomavirus and HIV among young women in Kampala, Uganda", J Infect Dis, 197, pp.555~562 (2008)
  36. Ndizeye Z, "Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control", PLoS One, 14, pp.e0209303~ (2019)
  37. Obiri-Yeboah D, "Epidemiology of cervical human papillomavirus(HPV)infection and squamous intraepithelial lesions(SIL)among a cohort of HIV-infected and uninfected Ghanaian women", BMC Cancer, 17, pp.688~ (2017)
  38. Ezechi OC, "The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women", Virol J, 11, pp.5~ (2014)
  39. Kelly HA, "Associations of human papillomavirus(HPV)genotypes with high-grade cervical neoplasia(CIN2+)in a cohort of women living with HIV in Burkina Faso and South Africa", PLoS One, 12, pp.e0174117~ (2017)
  40. Guthrie BL, "Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya", Sex Transm Infect, 96, pp.457~463 (2020)
  41. McDonald AC, "Distribution of human papillomavirus genotypes among HIV-positive and HIV-negative women in Cape Town, South Africa", Front Oncol, 4, pp.48~ (2014)
  42. Adebamowo SN, "Persistent low-risk and high-risk human papillomavirus infections of the uterine cervix in HIV-negative and HIV-positive women", Front Public Health, 5, pp.178~ (2017)
  43. Houlihan CF, "Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis", AIDS, 26, pp.2211~2222 (2012)
  44. Lissouba P, "Association of genital human papillomavirus infection with HIV acquisition : a systematic review and meta-analysis", Sex Transm Infect, 89, pp.350~356 (2013)
  45. Auvert B, "High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers", Infect Dis Obstet Gynecol, 2011, pp.692012~ (2011)
  46. Smith-McCune KK, "Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections", PLoS One, 5, pp.e10094~ (2010)
  47. Namujju PB, "Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and-negative Ugandan women", J Gen Virol, 92, pp.2776~2783 (2011)

이 간행물의 다른 논문 (102건)

Trends in the prevalence and management of major metabolic risk factors for chronic disease over 20 years: Findings from the 1998–2018 Korea National Health and Nutrition Examination Survey김영택, Kim Hyejin, Park Suyeon, 오경원, Park Ok, Yoonjung Kim, Nho Sun Jin, Woo Gyeongjipp. 1-12Letter to the Editor: Enhancing COVID-19 vaccination coverage using financial incentives: arguments to help health providers counterbalance erroneous claims최용준pp. 1-2Impact of early-life weight status on urinary tract infection in children: a nationwide population-based study in South Korea김봉성, 유기환, Han Kyung-do, Hyung Eun Yimpp. 1-9Trends in food and nutrient intake over 20 years: findings from the 1998-2018 Korea National Health and Nutrition Examination Survey김영택, 오경원, Park Jin Young, Park Suyeon, Yun Sungha, Kim Yangha, Yang Ji Eun, Park Ok, Sanghui Kweon, Park Myungsook, Yeon So Yeong, Yoon Leenapp. 1-9Trends in health behaviors over 20 years : Findings from the 1998-2018 Korea National Health and Nutrition Examination Survey김영택, 최선혜, Jihee Kim, Park Suyeon, 오경원, Park Ok, 김소연pp. 1-12
원문 보기